The U.S. government on Tuesday named the 15 new drugs targeted for Medicare price negotiations for 2028, including Gilead ...
Still, the medications in the latest round of negotiations — which now includes “Part B” drugs given in doctors offices — ...
The Trump administration released the next 15 drugs subject to Medicare price negotiation, including for the first time ...
Medicare lists cancer, arthritis, and HIV drugs for 2028 price negotiations, expanding its program to include Part B drugs administered in doctors' offices.
PROVIDENCE – Infectious disease doctors and public health advocates are raising concerns as Harvard Pilgrim, a health insurance provider, plans to phase out coverage of several HIV treatments next ...
HIV/AIDS activists heralded the approval of a new twice-yearly pre-exposure prophylaxis (PrEP) medication last year, but ...
The Trump administration has unveiled 15 new drugs selected for a Medicare drug price negotiation program that allows the ...
A newly approved drug gives almost total protection against getting HIV. The FDA approved lenacapavir last week. Patients need just two injections of it a year to get that protection, but as NPR's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results